IIT Assessing OC-01Nasal Spray on Symptoms of DED Following CXL

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
A Randomized, Controlled, Double-Masked, Two-Arm Investigator-Initiated study to Assess the Efficacy of OC-01 (varenicline) Nasal Spray on signs and symptoms of Dry Eye Disease in subjects following Corneal Collagen Crosslinking (CXL)
Epistemonikos ID: ba34e30825a0903444ccf8151c6e577f20a282f6
First added on: May 09, 2024